Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DUKE UNIVERSITY
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-06-14 to 2027-02-14
Current total value of award: $1457295
Description: NICHD: R&D: SAFETY OF SILDENAFIL IN PREMATURE INFANTS AT RISK OF BRONCHOPULMONARY DYSPLASIA (SILDENAFIL 2.0): NON-SEVERABLE